Conference Call and Webcast at 8:30AM Eastern Time
NEW
YORK, March 12, 2024 /PRNewswire/ -- Lucid
Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or
the "Company") a commercial-stage, cancer prevention medical
diagnostics company and majority-owned subsidiary of PAVmed Inc.
(Nasdaq: PAVM, PAVMZ), today announced that it will host a business
update conference call and webcast on Tuesday, March 26, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief
Executive Officer, will provide a business update, including an
overview of the Company's operations and continued growth strategy.
In addition, Dennis McGrath,
Lucid's Chief Financial Officer, will discuss the Company's
fourth-quarter and full year 2023 financial results.
The webcast will be available at the investor
relations section of the Company's website at luciddx.com.
Alternatively, to access the conference call by
telephone, U.S.-based callers should dial 1-800-836-8184 and
international listeners should dial 1-646-357-8785. All listeners
should provide the operator with the conference call name "Lucid
Diagnostics Business Update" to join.
Following the conclusion of the conference call, a replay will
be available for 30 days on the investor relations section of the
Company's website at luciddx.com.
About Lucid Diagnostics
Lucid Diagnostics Inc.
is a commercial-stage medical diagnostics company focused on cancer
prevention, and subsidiary of PAVmed Inc.
(Nasdaq: PAVM). Lucid is focused on the
millions of patients with gastroesophageal reflux
disease (GERD), also known as chronic heartburn, who
are at risk of developing esophageal precancer and
cancer. Lucid's EsoGuard® Esophageal
DNA Test, performed on samples collected in a brief, noninvasive
office procedure with its EsoCheck Esophageal Cell
Collection Device, is the first and only commercially available
diagnostic test capable of serving as a widespread screening tool
for at-risk patients to mitigate the risks of cancer and cancer
deaths through early detection of esophageal
precancer.
For more information, please visit www.luciddx.com and for more
information about its parent company PAVmed, please visit
www.pavmed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-march-26-2024-302086643.html
SOURCE Lucid Diagnostics